As of 2025-07-08, the Relative Valuation of PharmaCyte Biotech Inc (PMCB) is 1.14 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.10 USD, the upside of PharmaCyte Biotech Inc based on Relative Valuation is 3.8%.
The range of the Relative Valuation is 1.1 - 1.18 USD.
Range | Selected | |
Trailing P/E multiples | 0.4x - 0.4x | 0.4x |
Forward P/E multiples | 22.0x - 22.0x | 22x |
Fair Price | 1.1 - 1.18 | 1.14 |
Upside | 0.2% - 7.4% | 3.8% |
(USD in millions except Fair Price) | |||
Market Cap (USD mil) | Trailing P/E | Forward P/E | |
PharmaCyte Biotech Inc | 8 | 0.4x | 22x |
Industry median | 0.4x | 22x | |
(*) Profit after tax | 20 | 0 | |
Equity value | 8 | 8 | |
(/) Outstanding shares | 7 | 7 | |
Fair price | 1 | 1 | |
July 07, 2025 | 0.37 |
July 03, 2025 | 0.38 |
July 02, 2025 | 0.39 |
July 01, 2025 | 0.39 |
June 30, 2025 | 0.37 |
June 27, 2025 | 0.35 |
June 26, 2025 | 0.36 |
June 25, 2025 | 0.35 |
June 24, 2025 | 0.36 |
June 23, 2025 | 0.36 |
June 20, 2025 | 0.36 |
June 18, 2025 | 0.36 |
June 17, 2025 | 0.36 |
June 16, 2025 | 0.34 |
June 13, 2025 | 0.34 |
June 12, 2025 | 0.35 |
June 11, 2025 | 0.37 |
June 10, 2025 | 0.37 |
June 09, 2025 | 0.35 |
June 06, 2025 | 0.35 |
June 05, 2025 | 0.38 |
June 04, 2025 | 0.37 |
June 03, 2025 | 0.37 |
June 02, 2025 | 0.36 |
May 30, 2025 | 0.35 |
May 29, 2025 | 0.35 |
May 28, 2025 | 0.36 |
May 27, 2025 | 0.34 |
May 23, 2025 | 0.36 |
May 22, 2025 | 0.35 |
May 21, 2025 | 0.35 |
May 20, 2025 | 0.35 |
May 19, 2025 | 0.35 |
May 16, 2025 | 0.36 |
May 15, 2025 | 0.35 |
May 14, 2025 | 0.35 |
May 13, 2025 | 0.36 |
May 12, 2025 | 0.36 |
May 09, 2025 | 0.38 |
May 08, 2025 | 0.39 |
May 07, 2025 | 0.37 |
May 06, 2025 | 0.38 |
May 05, 2025 | 0.41 |
May 02, 2025 | 0.41 |
May 01, 2025 | 0.4 |
April 30, 2025 | 0.42 |
April 29, 2025 | 0.42 |
April 28, 2025 | 0.41 |
April 25, 2025 | 0.41 |
April 24, 2025 | 0.41 |